Therma Bright Partners With Afero To Make AcuVid(TM) COVID-19 Rapid Antigen Saliva Test Smart-Enabled
Silicon Valley tech firm brings encrypted solution for tracking Canadian developer's 15-minute Covid19 rapid antigen test for point of care, and then at-home testing
- The mutually beneficial partnership looks to bring Afero\'s innovation, security and tracking technology to Therma Bright\'s 15-minute COVID-19 rapid antigen screening solution.
- It also paves the way for preparing the AcuVID COVID-19 Rapid Antigen Test for approval for at-home testing.
- The Afero encrypted QR Code solution will be embedded on each Acuvid Rapid Antigen Test for both enterprise and consumer use.
- "Therma Bright\'s AcuVid COVID-19 Rapid Antigen Test, powered by Afero, is measurable progress towards enabling everyone on the planet to be able to take a secure, simple, reliable saliva-based test.